MicroPort MedBot (2252) Receives Approval for H Share Full Circulation

Bulletin Express
02/13

Shanghai MicroPort MedBot (Group) Co., Ltd. (Stock Code: 2252) has announced that on 13 February 2026 it received listing approval from The Stock Exchange of Hong Kong Limited for the conversion and listing of 5.99 million unlisted shares, representing about 0.58% of the company’s total issued share capital.

These shares are to be converted into H shares held by two participating shareholders. After the conversion, the total number of unlisted shares will decline to approximately 0.06% of the company’s total issued share capital, while H shares will rise to 99.94%. The total number of shares remains at 1,031.33 million.

The company will complete the relevant procedures and disclose further progress of the H share full circulation process as required. Shareholders and potential investors are advised to exercise caution when dealing in the company’s shares.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10